Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue March 2015
 •  Pravana To Host National Cut-A-Thon  •  Lonza Promotes Cataldo In Personal Care  •  Hair Lightening System Now at Target  •  Better Skin, Better Sleep  •  J&J's New Approach to Beauty
Print

Valeant To Buy Bausch & Lomb



Published May 27, 2013
Related Searches: skin health care industry
Post a comment
Valeant To Buy Bausch & Lomb

Valeant Pharmaceuticals International will pay $8.7 billion to acquire Bausch & Lomb, the eye care company. Under the terms of the deal, Valeant will pay $4.5 billion to the investor group that owns Bausch & Lomb, led by private equity firm Warburg Pincus. It will also spend about $4.2 billion to repay Bausch & Lomb’s debt.

 

The agreement continues the flurry of deal-making in the health care industry, as companies seek to buy the growth they are hard-pressed to generate on their own. Announced merger volume in the sector this year is up 14% from the period a year earlier, even as takeovers have fallen 8%.


This acquisition follows Valeant's April purchase for Obagi skin care for $348 million.

 



blog comments powered by Disqus